Northwire Canada EditionFriday, July 17, 2026
Northwire
FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.04 −0.9% SFR 0.370 +68.2% OMM 0.050 +0.0% EMO 0.325 −5.8% GGA 5.90 +11.3% MDM 0.060 +0.0% WGX 4.30 −2.9% FL 0.410 +0.0% SSRM 35.92 −1.2% CD 0.240 +4.3% GEN 0.065 −7.1% ALS 55.34 −3.7% LIFT 3.35 +6.3% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.04 −0.9% SFR 0.370 +68.2% OMM 0.050 +0.0% EMO 0.325 −5.8% GGA 5.90 +11.3% MDM 0.060 +0.0% WGX 4.30 −2.9% FL 0.410 +0.0% SSRM 35.92 −1.2% CD 0.240 +4.3% GEN 0.065 −7.1% ALS 55.34 −3.7% LIFT 3.35 +6.3%
M&A / Property

Datametrex AI hires Pelent for licensing

DM · Price

Executive Summary

  • Datametrex AI Ltd.'s wholly owned subsidiary, Paymetrex Payment Solutions Inc., has engaged Pelent Patent Analytics to accelerate its patent licensing and monetization program.
  • The engagement integrates Pelent’s AI engine, which utilizes confidential, real-world licensing data to identify high-probability licensing targets and strengthen the company's ability to unlock value from its intellectual property portfolio.
  • This move supports Paymetrex’s recently launched comprehensive patent licensing program, which has already secured its first non-exclusive United States license agreement providing for annual royalty payments.

Key Details

  • Parties Involved: Paymetrex Payment Solutions Inc. (subsidiary of Datametrex AI Ltd.) and Pelent Patent Analytics.
  • Effective Date: February 13, 2026.
  • Purpose: To enhance and accelerate Paymetrex's patent licensing and monetization program by integrating Pelent's AI into the licensing workflow.
  • Pelent AI Capabilities:
    • Built around thousands of high-value patent licensing campaigns, including confidential data unavailable through public sources.
    • Evaluates patents through a commercial and enforcement lens rather than relying solely on academic indicators or citation-based metrics.
    • Designed to recognize the "DNA" of valuable patents based on actual licensing and enforcement characteristics.
  • Strategic Benefits for Paymetrex:
    • Identify companies whose products/platforms may utilize technologies covered by Paymetrex's patents.
    • Prioritize enforcement and licensing opportunities based on commercial viability.
    • Accelerate engagement timelines with prospective licensees.
    • Optimize and expand the overall patent monetization strategy.
  • Current Licensing Status: Paymetrex recently announced its first non-exclusive United States license agreement, which provides for annual royalty payments over the life of the applicable patents.
  • Engagement Terms:
    • Initial term: Four months.
    • Renewal options available by mutual agreement.
    • Fee structure: Monthly services and a fee for evidence of use preparation per documented patent.
    • Fees are payable monthly and exclusive of applicable taxes.
    • No finders' fees are payable in connection with this engagement.

Notable Quotes

  • Richard Moses, Founder of Pelent: "Most AI systems in the patent space rely on publicly scraped data and generalized models... Pelent was built differently. It was designed around actual patent licensing and trained to recognize the underlying characteristics -- the 'DNA' -- that distinguish valuable patents from the rest."
  • Paul Haber, CEO of Datametrex: "Engaging Pelent represents a strategic step forward in scaling our patent licensing program... This engagement significantly strengthens our ability to identify and pursue high-value opportunities."
Read the original news release →

More from Datametrex AI Ltd